↓ Skip to main content

Resistance to Proteasome Inhibitors in Cancer

Overview of attention for book
Cover of 'Resistance to Proteasome Inhibitors in Cancer'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Proteasome Inhibitors and Lessons Learned from Their Mechanisms of Action and Resistance in Human Cancer
  3. Altmetric Badge
    Chapter 2 Resistance to Proteasome Inhibitors in Multiple Myeloma
  4. Altmetric Badge
    Chapter 3 Overcoming Bortezomib Resistance: A Review of the Second-Generation Proteasome Inhibitor Carfilzomib in the Treatment of Multiple Myeloma
  5. Altmetric Badge
    Chapter 4 Proteasome Inhibitors in the Treatment of Multiple Myeloma and AL Amyloidosis
  6. Altmetric Badge
    Chapter 5 Profiling Bortezomib Resistance in Multiple Myeloma: Implications in Personalized Pharmacotherapy
  7. Altmetric Badge
    Chapter 6 Targeting Mantle Cell Lymphoma with a Strategy of Combined Proteasome and Histone Deacetylase Inhibition
  8. Altmetric Badge
    Chapter 7 Preclinical Studies on the Molecular Basis of Bortezomib Resistance and Modalities to Overcome Resistance in Hematological Malignancies
  9. Altmetric Badge
    Chapter 8 Overcoming Inherent Resistance to Proteasome Inhibitors in Head and Neck Cancer: Challenges and New Approaches
  10. Altmetric Badge
    Chapter 9 Targeting the Proteasome Pathway for the Treatment of Solid Tumors
  11. Altmetric Badge
    Chapter 10 Oxidative Stress and the Proteasome: Mechanisms and Therapeutic Relevance
  12. Altmetric Badge
    Chapter 11 Proteotoxic Stress and Proteasome Inhibitor Efficacy and Resistance
  13. Altmetric Badge
    Chapter 12 Proteasome Inhibitors Versus E3 Ligase Inhibitors for Cancer Therapy
  14. Altmetric Badge
    Chapter 13 Novel Ubiquitin E3 Ligases as Targets for Cancer Therapy: Focus on Breast Cancer-Associated Gene 2 (BCA2)
  15. Altmetric Badge
    Chapter 14 The 26S Proteasomal ATPases: Structure, Function, Regulation, and Potential for Cancer Therapies
  16. Altmetric Badge
    Chapter 15 Deubiquitinating Enzymes as Novel Targets for Cancer Therapies
Overall attention for this book and its chapters
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Resistance to Proteasome Inhibitors in Cancer
Published by
Springer International Publishing, September 2014
DOI 10.1007/978-3-319-06752-0
ISBNs
978-3-31-906751-3, 978-3-31-906752-0
Editors

Dou, Q. Ping

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 5%
Student > Master 2 5%
Student > Ph. D. Student 1 3%
Other 1 3%
Researcher 1 3%
Other 1 3%
Unknown 32 80%
Readers by discipline Count As %
Agricultural and Biological Sciences 5 13%
Biochemistry, Genetics and Molecular Biology 1 3%
Medicine and Dentistry 1 3%
Unknown 33 83%